ERAS Markets Signal, Research & Overview

Timing · 1D

Technicals

Summary

Neutral

57

9 5 13

Oscillators

Neutral

40

4 4 2

Moving averages

Buy

68

5 1 11

Indicator details →

Signal & events

Model signalUnavailable

EarningsAug 12, 2026

CatalystsData pending

Signal history →Earnings & events →

Company data

Fundamentals

Full fundamentals →

Valuation

Market Cap$6.3B

Growth and income

Eps-0.93

Free Cash Flow$-212.71M

Net Income$-183.44M

Profitability

Ebitda$-130.68M

Balance sheet

Free Cash Flow$-212.71M

Total Assets$461.23M

Total Liabilities$67.71M

Dividends

Payout Ratio0.00%

Trailing Annual Dividend Rate0

Trailing Annual Dividend Yield0.00%

Financial statements →Valuation history →Ownership & capital →

Observed associations

Relationships

View all →

GLUEMONTE ROSA THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement AVBPARRIVENT BIOPHARMA INC+0.00%Market co-movement · Residual co-movement RLAYRELAY THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement TNGXTANGO THERAPEUTICS INC+0.00%Market co-movement · Residual co-movement PCVXVAXCYTE INC+0.00%Residual co-movement · Market co-movement

RelationshipsLoading

ERASCA INC

Quick Read

Technicals

Fundamentals

Valuation

Growth and income

Profitability

Balance sheet

Dividends

Relationships

Relationships